Abstract
Case 1 presented to us in 1982, at age 67, after taking levothyroxine (T4) for 10 yr. Her thyroid was nontender, quite firm, and diffusely enlarged, with an estimated size of 50 g. Her antithyroid microsomal antibody titer was 1:1 600,000 and her antithyroglobulin antibody level was 50 radioimmunoassay (RIA) units*. On a T4 dose of 150 pg daily, her serum thyrotropin [thyroid stimulating hormone (TSH)] level was 3.5 mU/L (normal 0.5–5.2). The presumed diagnosis was chronic lymphocytic (Hashimoto’s) thyroiditis. T4 was continued. In 1987, because her thyroid size had not decreased, she had a fine-needle aspiration biopsy (FNAB), that produced only a few groups of oxyphilic follicular cells (Hürthle cells), consistent with Hashimoto’s thyroiditis, but insufficient for a definite diagnosis. Her goiter was stable until May 1995, when she reported 2 wk of severe anterior neck pain that radiated to her ears and jaw. Thyroid size was still about 50 g, the erythrocyte sedimentation rate (ESR) was 76 mm/h (normal up to 18) and the white blood cell count (WBC) was normal.
Keywords
- Celiac Disease
- Thyroid Stimulate Hormone
- Autoimmune Thyroid Disease
- Thyroid Stimulate Hormone Level
- Hypothyroid Patient
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
LiVolsi VA. Pathology of thyroid diseases. In: Braverman LE, Utiger RD, eds. Werner and Ingbar’s The Thyroid, 8th ed. Lippincott Williams & Wilkins, Philadelphia, PA, 2000, pp. 490–491.
LiVolsi VA. The pathology of autoimmune thyroid disease: a review. Thyroid 1994; 4: 333–339.
DeGroot U, Larsen PR, Hennemann G. Hashimoto’s thyroiditis. In: DeGroot Li, Larsen PR, Hennemann G, eds. The Thyroid and Its Diseases, 6th ed., Churchill Livingstone, New York, 1996, pp. 309–310.
Zimmerman RS, Brennan MD, McConahey WM, et al. Hashimoto’s thyroiditis, an uncommon cause of painful thyroid unresponsiveness to corticosteroid therapy. Ann Intern Med 1986; 104: 355–357.
Shigemasa C, Ueta Y, Mitani Y, et al. Chronic thyroiditis with painful tender thyroid enlargement and transient thyrotoxicosis. J Clin Endocrinol Metab 1990; 70: 385–390.
Volpe R. Subacute thyroiditis. In: Burrow GN, Oppenheimer JH, Volpe R, eds. Thyroid Function and Disease. Saunders, Philadelphia, PA, 1990, p. 188.
Lazarus JH. Silent thyroiditis and subacute thyroiditis. In: Braverman LE, Utiger RD, eds. Werner and Ingbar’s The Thyroid, 7th ed. Lippincott-Raven, Philadelphia, PA, 1996, p. 584.
Hamburger JI, Kadian G, Rossin HW. Subacute thyroiditis evolution depicted by serial 1311 scintigram. J Nucl Med 1965; 6: 560–565.
Shigemasa C, Ueta Y, Mitani Y, et al. Chronic thyroiditis with painful tender thyroid enlargement and transient thyrotoxicosis. J Clin Endocrinol Metab 1990; 70: 385–390.
Stanley JM, Najjar SS. Painful thyroid gland: an atypical presentation of Graves’disease. Clin Endocrinol 1992; 27: 468–469.
Fukata S, Matsuzuka, F, Hara T, et al. Rapidly progressive thyroid failure in Graves’disease after painful attack in the thyroid gland. Arch Intern Med 1987; 107: 118–119.
Ikenoue H, Okamura K, Kuroda T, et al. Thyroid amyloidosis with recurrent subacute thyroiditis-like syndrome. J Clin Endocrinol Metab 1988; 67: 41–45.
Drucker DJ, Bailey D, Rotstein L. Thyroiditis as the presenting manifestation of disseminated extrapulmonary pneumocystis carinii infection. J Clin Endocrinol Metab 1990; 71: 1663–1665.
Prakash R, Jayaram G, Singh RP. Follicular thyroid carcinoma masquerading as subacute thyroiditis. Australas Radiol 1991; 35: 174–177.
Watts NB, Sewell CW. Case report: carcinomatous involvement of the thyroid presenting as subacute thyroiditis. Am J Med Sci 1998; 296: 126–128.
Hamburger JI, Taylor CI. Transient thyrotoxicosis associated with acute hemorrhagic infarction of autonomously functioning thyroid nodules. Ann Intern Med 1979; 91: 406–409.
Kossev P, LiVolsi VA. Lymphoid lesion of the thyroid: review in light of the revised European-American lymphoma classification and upcoming World Health Organization classification. Thyroid 1999; 9: 1273–1280.
Hamburger JI, Miller JM, Kini SR. Lymphoma of the thyroid. Ann Int Med 1983; 99: 685–693.
Vailati A, Marcena C, Aristia L, et al. Primary Hodgkin’s disease of the thyroid: report of a case and review of the literature. Haematologica 1991; 76: 69–71.
Granados R, Pinkus G, West P, et al. Hodgkin’s disease presenting as an enlarged thyroid gland. Report of a case diagnosed by fine needle biopsy aspiration. Acta Cytol 1991; 35: 439–441.
Choe W, Hays MT. Absorption of oral thyroxine. The Endocrinologist 1995; 5: 222–228.
Wenzel KW, Kirschsieper HE. Aspects of the absorption of oral l-thyroxine in normal man. Metabolism 1977; 26; 1–8.
Rosenbaum RL, Barzel US. Levothyroxine replacement dose for primary hypothyroidism decreases with age. Ann Intern Med 1982; 96: 53–55.
Swain CT, Herman T, Molitch ME, et al. Aging and the thyroid. Decreased requirement for thyroid hormone in older hypothyroid patients. Am J Med 1983; 75: 206–209.
Kaplan MM. Management of thyroxine therapy during pregnancy. Endocr Pract 1996; 2: 281–286.
Jauk B, Mikosch HJ, Gallowitsch E, et al. Case history. Unusual malabsorption of levothyroxine. Thyroid 2000; 10: 93–95.
Campbell NR, Hasinoff BB, Stalts H, et al. Ferrous sulfate reduces thyroxine efficiency in patients with hypothyroidism. Ann Intern Med 1991; 117: 1010–1013.
Harmon SM, Seifert CF. Levothyroxine-cholestyramine interaction reemphasized (letter). Ann Intern Med 1991; 115: 658–659.
Sherman SI, Tielens ET, Ladenson PW. Sucralfate causes malabsorption of 1-thyroxine. Am J Med 1994; 96: 531–535.
McCowen MB, Garber JR, Spark R. Elevated serum thyrotropin in thyroxine-treated patients with hypothyroidism given sertraline (letter). N Engl J Med 1997; 337: 1010–1011.
Demke DM. Drug interaction between thyroxine and lovastatin (letter). N Engl J Med 1989; 321: 1341 1342.
McLean M, Kirkwood I, Epstein M, et al. Cation-exchange resin and inhibition of intestinal absorption of thyroxine. Lancet 1993; 341: 1286.
Liel Y, Sperber AD, Shany S, et al. Nonspecific intestinal adsorption of levothyroxine by aluminum hydroxide. Am J Med 1994; 97: 363–365.
Liel Y, Harman-Boehm I, Shany S. Evidence for a clinically important adverse effect of fiber-enriched diet on the bioavailability of levothyroxine in adult hypothyroid patients. J Clin Endocrinol Metab 1996; 81: 857–859.
Chiu AC, Sherman SI. Effects of pharmacological fiber supplements in levothyroxine absorption. Thyroid 1998;8:667— 671.
Pinchera A, MacGillivray MH, Crawford JD, et al. Thyroid refractoriness in an athyreotic cretin fed soybean formula. N Engl J Med 1965;273:83–87
Schneyer C. Calcium carbonate and reduction of levothyroxine efficiency (letter). JAMA 1998; 279: 750.
Butner LE, Fulco PP, Feldman G. Calcium carbonate-induced hypothyroidism (letter). Ann Intern Med 2000; 132: 595.
Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine. JAMA 2000; 283: 2822–2825.
McIver B, Morris JC. The pathogenesis of Graves’disease. Endocrinol Metab Clin North Am 1998; 27: 7–89.
Takasu N, Yamada T, Takusa M, et al. Disappearance of thyrotropin-blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis. N Engi J Med 1992; 326: 513–518.
Wood LC, Ingbar SH. Hypothyroidism as a late sequela in patients with Graves’disease treated with antithyroid agents. J Clin Invest 1979; 64: 1429–1436.
Hirota Y, Tamai H, Hayashi Y, et al. Thyroid function and histology in forty-five patients with hyperthyroid Graves’disease in clinical remission more than ten years after thionamide drug treatment. J Clin Endocrinol Metab 1986; 62: 165–169.
Tamai H, Kasagi K, Takaichi Y, et al. Development of spontaneous hypothyroidism in patients with Graves’disease treated with antithyroid drugs: clinical, immunological, and histological findings in 26 patients. J Clin Endocrinol Metab 1989: 69: 49–53.
Rieu M, Richard A, Rosilio M, et al. Effects of thyroid status on thyroid autoimmunity expression in euthyroid and hypothyroid patients with Hashimoto’s thyroiditis. Clin Endocrinol 1994; 40: 529–535.
Takasu N, Komiya I, Asawa T, et al. Test for recovery from hypothyroidism during thyroxine therapy in Hashimoto’s thyroidits. Lancet 1990; 336: 1084–1086.
Comtois R, Faucher L, Lafleche L. Outcome of hypothyroidism caused by Hashimoto’s thyroiditis. Arch Intern Med 1995; 155: 1404–1408.
Utiger RD. Vanishing hypothyroidism (editorial). N Engl J Med 1992; 326: 562–563.
Fatourechi V, Gharib H. Hyperthyroidism following hypothyroidism. Data on six cases. Arch Intern Med 1988; 148: 976–978.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Meier, D.A., Kaplan, M.M. (2002). Hypothyroidism and Thyroiditis. In: Molitch, M.E. (eds) Challenging Cases in Endocrinology. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-277-7_5
Download citation
DOI: https://doi.org/10.1007/978-1-59259-277-7_5
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-249-0
Online ISBN: 978-1-59259-277-7
eBook Packages: Springer Book Archive